Jagsonpal Pharmaceuticals

250.96
-7.95
(-3.07%)
Market Cap
1,665.49
Eps
8.49
PE Ratio (TTM)
47.13
Dividend Yield
0.77
Industry
Healthcare
52 Week High
328.04
52 Week low
109.44
PB Ratio
8.71
Debt to Equity
0.04
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-10.07 %
Net Income Growth
-15.73 %
Cash Flow Change
-24.62 %
ROE
-28.72 %
ROCE
-26.33 %
EBITDA Margin (Avg.)
-9.79 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
138
144
144
127
168
161
192
221
242
218
285
Expenses
129
132
138
138
158
150
169
193
203
186
212
EBITDA
9
13
6
-11
11
11
24
29
40
32
73
Operating Profit %
6 %
8 %
4 %
-9 %
6 %
5 %
10 %
12 %
14 %
11 %
15 %
Depreciation
3
3
2
0
1
1
1
2
1
2
6
Interest
5
5
3
1
1
1
1
0
0
1
1
Profit Before Tax
2
4
14
-12
9
9
22
27
35
30
66
Tax
1
1
3
-0
2
2
5
8
8
7
13
Net Profit
1
3
12
-12
7
8
17
19
27
23
52
EPS in ₹
0.45
1.24
4.53
-4.41
2.75
3.00
6.51
7.20
10.20
8.49
12.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
154
159
143
130
136
147
164
164
195
217
Fixed Assets
52
52
22
21
22
22
26
23
24
9
Current Assets
96
101
110
95
98
95
121
109
165
199
Capital Work in Progress
0
0
0
3
4
4
0
0
0
0
Investments
0
0
0
0
0
11
15
51
1
0
Other Assets
102
108
121
106
110
109
123
91
170
208
Total Liabilities
154
159
143
130
136
147
164
164
195
217
Current Liabilities
55
57
29
29
28
33
40
27
28
19
Non Current Liabilities
4
4
3
3
3
3
2
5
9
11
Total Equity
95
98
110
98
105
111
122
133
159
187
Reserve & Surplus
82
85
97
85
91
98
109
120
146
174
Share Capital
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
1
5
-6
24
-1
19
-36
-12
2
Investing Activities
-1
-2
41
-3
-1
-11
-2
-26
-58
-25
Operating Activities
4
9
-3
-2
31
11
28
7
47
35
Financing Activities
-1
-6
-34
-1
-6
-1
-7
-18
-1
-9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
70.34 %
70.34 %
70.34 %
70.34 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.48 %
68.09 %
68.04 %
67.97 %
67.81 %
FIIs
0.00 %
0.00 %
0.11 %
0.20 %
0.00 %
0.00 %
0.13 %
0.00 %
0.00 %
0.00 %
0.38 %
0.00 %
0.73 %
1.10 %
2.30 %
2.10 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.28 %
0.77 %
0.83 %
0.83 %
0.83 %
0.00 %
0.85 %
0.85 %
0.11 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.67 %
26.08 %
23.71 %
23.71 %
22.92 %
25.27 %
22.78 %
21.11 %
22.23 %
22.84 %
21.99 %
21.94 %
20.69 %
20.79 %
20.38 %
20.64 %
No of Share Holders
0
12,546
14,655
14,353
20,031
17,100
16,194
14,952
14,084
13,782
16,041
15,785
16,282
15,748
15,633
18,471

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,752.75 4,20,543.44 35.94 49,887.20 12.06 9,648 13.77 44.79
6,123.50 1,62,559.68 78.25 8,184.00 0.89 1,600 64.53 60.08
1,436.80 1,16,037.99 23.45 26,520.70 14.17 4,155 47.38 46.67
3,114.70 1,05,415.60 56.43 10,785.70 11.59 1,656 13.54 35.94
2,483.00 1,02,440.36 51.56 10,615.60 19.57 1,942 -16.38 42.73
1,227.55 1,02,428.11 18.95 28,905.40 12.36 5,578 1.69 41.25
2,185.10 99,683.73 36.66 20,141.50 19.94 1,936 73.53 56.12
977.00 98,309.06 22.90 19,831.50 13.82 3,831 29.92 51.89
1,191.75 69,217.03 18.82 29,559.20 17.55 3,169 8.66 48.98
5,117.95 61,192.77 28.08 12,978.40 9.84 1,812 14.16 43.89

Corporate Action

Technical Indicators

RSI(14)
Neutral
56.52
ATR(14)
Less Volatile
21.87
STOCH(9,6)
Neutral
72.64
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
4.37
ADX(14)
Weak Trend
18.57
UO(9)
Bearish
49.51
ROC(12)
Uptrend And Accelerating
17.10
WillR(14)
Neutral
-22.34